At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

SAN DIEGO --(BUSINESS WIRE)--Nov. 10, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 , at 3:20 p.m. Eastern Time . The conference will be held virtually.
- 3Q20 Net Sales of $120.6 Million , a 27% Increase Over 3Q19 SAN DIEGO --(BUSINESS WIRE)--Nov. 4, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central
SAN DIEGO --(BUSINESS WIRE)--Oct. 26, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that scientific presentations highlighting new analyses of pimavanserin clinical study data in dementia-related psychosis and neurodegenerative diseases will be shared at the 13 th Clinical